3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Terminated
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Breast
1
Conditions
Breast Neoplasms
2
Gastrointestinal Neoplasms
1
Fatigue
1
Cognitive Dysfunction
1
Interventions
Transcranial Direct Current Stimulation
4
Walking
2
lime
1
Ultraviolet Therapy
1
Tai Ji
1
Sugars
1
Standard of Care
1
Sodium Chloride
1
Silymarin
1
Organization and Administration
1
Methylphenidate
1
Memantine
1
Low-Level Light Therapy
1
G(M1) Ganglioside
1
Equine-Assisted Therapy
1
Drug Therapy
1
Donepezil
1
Docosahexaenoic Acids
1
Cognitive Training
1
Cognitive Behavioral Therapy
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Cognitive Dysfunction
×
Methylphenidate
×
Breast
×
Clear all
NCT02970500
2023-03-23
CogMet
CHU de Quebec-Universite Laval
Phase 2
Terminated
20 enrolled